Cargando…

Epigenetic regulation of L1CAM in endometrial carcinoma: comparison to cancer–testis (CT-X) antigens

BACKGROUND: L1CAM was originally identified as an adhesion molecule involved in neural development. In many human carcinomas L1CAM is over-expressed and is associated with a bad prognosis. We previously reported that L1CAM was absent in the vast majority of endometrioid endometrial carcinomas (ECs)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schirmer, Uwe, Fiegl, Heidi, Pfeifer, Marco, Zeimet, Alain G, Müller-Holzner, Elisabeth, Bode, Peter K, Tischler, Verena, Altevogt, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3626534/ https://www.ncbi.nlm.nih.gov/pubmed/23530769 http://dx.doi.org/10.1186/1471-2407-13-156

Ejemplares similares

Correction to: Epigenetic regulation of L1CAM in endometrial carcinoma: comparison to cancer–testis (CT-X) antigens
por: Schirmer, Uwe, et al.
Publicado: (2018)

Role of miR-34a as a suppressor of L1CAM in endometrial carcinoma
por: Schirmer, Uwe, et al.
Publicado: (2014)

Evaluating L1CAM expression in human endometrial cancer using qRT-PCR
por: Notaro, Sara, et al.
Publicado: (2016)

L1CAM expression in endometrial carcinomas is regulated by usage of two different promoter regions
por: Pfeifer, Marco, et al.
Publicado: (2010)

L1CAM protein expression is associated with poor prognosis in non-small cell lung cancer
por: Tischler, Verena, et al.
Publicado: (2011)

L1CAM is expressed in triple-negative breast cancers and is inversely correlated with Androgen receptor
por: Doberstein, Kai, et al.
Publicado: (2014)

Detection of soluble EpCAM (sEpCAM) in malignant ascites predicts poor overall survival in patients treated with catumaxomab
por: Seeber, Andreas, et al.
Publicado: (2015)

Clinical impact of L1CAM expression measured on the transcriptome level in ovarian cancer
por: Azim, Samira Abdel, et al.
Publicado: (2016)

Evaluation of Vav3.1 as prognostic marker in endometrial cancer
por: Boesch, Maximilian, et al.
Publicado: (2018)

Expression and promotor hypermethylation of miR-34a in the various histological subtypes of ovarian cancer
por: Schmid, Gabriel, et al.
Publicado: (2016)

Clinical impact of EZH2 and its antagonist SMARCA4 in ovarian cancer
por: Leitner, Katharina, et al.
Publicado: (2020)

L1CAM Expression is Related to Non-Endometrioid Histology, and Prognostic for Poor Outcome in Endometrioid Endometrial Carcinoma
por: Geels, Yvette P., et al.
Publicado: (2016)

A comparison of four technologies for detecting p53 aggregates in ovarian cancer
por: Heinzl, Nicole, et al.
Publicado: (2022)

High RIG‐I expression in ovarian cancer associates with an immune‐escape signature and poor clinical outcome
por: Wolf, Dominik, et al.
Publicado: (2019)

Clinical Impact of RANK Signalling in Ovarian Cancer
por: Wieser, Verena, et al.
Publicado: (2019)

NrCAM secreted by endometrial stromal cells enhances the progestin sensitivity of endometrial cancer cells through epigenetic modulation of PRB
por: Cheng, Yali, et al.
Publicado: (2022)

Evaluation of folate receptor 1 (FOLR1) mRNA expression, its specific promoter methylation and global DNA hypomethylation in type I and type II ovarian cancers
por: Notaro, Sara, et al.
Publicado: (2016)

Tumor necrosis factor receptor modulator spermatogenesis‐associated protein 2 is a novel predictor of outcome in ovarian cancer
por: Wieser, Verena, et al.
Publicado: (2019)

Role of DNA Methylation and Epigenetic Silencing of HAND2 in Endometrial Cancer Development
por: Jones, Allison, et al.
Publicado: (2013)

High prevalence of side population in human cancer cell lines
por: Boesch, Maximilian, et al.
Publicado: (2016)

Integrative Discovery of Epigenetically Derepressed Cancer Testis Antigens in NSCLC
por: Glazer, Chad A., et al.
Publicado: (2009)

BRCA1/2 and TP53 mutation status associates with PD-1 and PD-L1 expression in ovarian cancer
por: Wieser, Verena, et al.
Publicado: (2018)

BRCA1 and BRCA2 mRNA-expression prove to be of clinical impact in ovarian cancer
por: Tsibulak, Irina, et al.
Publicado: (2018)

The miR-34 family and its clinical significance in ovarian cancer
por: Welponer, Hannah, et al.
Publicado: (2020)

Nuclear translocation and signalling of L1-CAM in human carcinoma cells requires ADAM10 and presenilin/γ-secretase activity
por: Riedle, Svenja, et al.
Publicado: (2009)

L1CAM expression in endometrial carcinomas: an ENITEC collaboration study
por: van der Putten, Louis JM, et al.
Publicado: (2016)

Cancer-Testis Antigen Expression in Serous Endometrial Cancer with Loss of X Chromosome Inactivation
por: Kang, Jun, et al.
Publicado: (2015)

Full-Length L1CAM and Not Its Δ2Δ27 Splice Variant Promotes Metastasis through Induction of Gelatinase Expression
por: Hauser, Stephanie, et al.
Publicado: (2011)

The sL1CAM in sera of patients with endometrial and ovarian cancers
por: Wojciechowski, Michał, et al.
Publicado: (2016)

L1CAM as a prognostic marker in stage I endometrial cancer: a validation study
por: Smogeli, Elisabeth, et al.
Publicado: (2016)

Epigenetic Regulation of Sox30 Is Associated with Testis Development in Mice
por: Han, Fei, et al.
Publicado: (2014)

miR-888: A Novel Cancer-Testis Antigen that Targets the Progesterone Receptor in Endometrial Cancer()()
por: Hovey, Adriann M., et al.
Publicado: (2015)

Serum HE4 detects recurrent endometrial cancer in patients undergoing routine clinical surveillance
por: Brennan, Donal J, et al.
Publicado: (2015)

L1CAM is required for early dissemination of fallopian tube carcinoma precursors to the ovary
por: Doberstein, Kai, et al.
Publicado: (2022)

Epigenetic variability in cells of normal cytology is associated with the risk of future morphological transformation
por: Teschendorff, Andrew E, et al.
Publicado: (2012)

Distinguishing epigenetic features of preneoplastic testis tissues adjacent to seminomas and nonseminomas
por: Gainetdinov, Ildar V., et al.
Publicado: (2016)

Monitoring physical and psychosocial symptom trajectories in ovarian cancer patients receiving chemotherapy
por: Meraner, Verena, et al.
Publicado: (2012)

High STAT1 mRNA levels but not its tyrosine phosphorylation are associated with macrophage infiltration and bad prognosis in breast cancer
por: Tymoszuk, Piotr, et al.
Publicado: (2014)

L1CAM is not a reliable predictor for lymph node metastases in endometrial cancer, but L1CAM positive patients benefit from radiotherapy
por: Zeiter, Deborah, et al.
Publicado: (2021)

Fetal testis organ culture reproduces the dynamics of epigenetic reprogramming in rat gonocytes
por: Rwigemera, Arlette, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_kkhvgp5897bqdpq74duoe39hm0